Analyzing INVO Fertility (NASDAQ:IVF) and Titan Medical (NASDAQ:TMDIF)

INVO Fertility (NASDAQ:IVF) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, earnings, dividends, profitability and risk.

Profitability

This table compares INVO Fertility and Titan Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-417.02%	N/A	-92.42%
Titan Medical	N/A	-82.31%	-51.47%

Institutional & Insider Ownership

12.0% of INVO Fertility shares are held by institutional investors. Comparatively, 0.0% of Titan Medical shares are held by institutional investors. 0.7% of INVO Fertility shares are held by insiders. Comparatively, 0.0% of Titan Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares INVO Fertility and Titan Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.53 million	0.32	-$9.10 million	($630.30)	0.00
Titan Medical	$17.63 million	2.10	$6.95 million	$0.05	6.50

Titan Medical has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations and price targets for INVO Fertility and Titan Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1	0	0	0	1.00
Titan Medical	0	0	0	0	0.00

Risk & Volatility

INVO Fertility has a beta of 2.54, suggesting that its share price is 154% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.

About Titan Medical

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.